The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Alnylam Pharmaceuticals (United States) · Acuitas Therapeutics (Canada) · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,548
total citations
- FWCI
- 42.55
- Percentile
- 100%
- References
- 22
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Nucleic acid
- Translation (biology)
- Nanotechnology
- Small interfering RNA
- Drug delivery
- RNA
- Transthyretin
- Chemistry
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.